Mimedx (MDXG) Gross Margin Growth (5y) (2016 - 2026)

Mimedx (MDXG) Gross Margin Growth (5y) (2016 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Mimedx 615.09 Mn 455.31 Mn 41.62 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -1,336.00
Dec 31, 2025 -35.00
Sep 30, 2025 -46.00
Jun 30, 2025 -366.00
Mar 31, 2025 -253.00
Dec 31, 2024 -157.00
Sep 30, 2024 -337.00
Jun 30, 2024 -258.00
Mar 31, 2024 -419.00
Dec 31, 2023 -471.00
Sep 30, 2023 -964.00
Jun 30, 2023 -700.00
Mar 31, 2023 -621.00
Dec 31, 2022 -862.00
Sep 30, 2022 -693.00
Jun 30, 2022 -714.00
Mar 31, 2022 -520.00
Dec 31, 2021 -99.00
Sep 30, 2021 -365.00
Jun 30, 2021 -582.00